A Paradigm Shift in Ferroptosis Defense

For years after ferroptosis was discovered, scientists believed that GPX4 was the sole guardian protecting cells from iron-dependent death. GPX4 uses glutathione to detoxify lipid peroxides, and when GPX4 fails, ferroptosis occurs. This model was elegant and seemingly complete.

Then in 2019, everything changed.

Multiple research groups independently discovered that some cells could survive even when GPX4 was completely eliminated. This shouldn’t have been possible according to the existing model—without GPX4 to detoxify lipid peroxides, cells should die. But they didn’t.

The answer came from the discovery of FSP1 (Ferroptosis Suppressor Protein 1) and its partnership with coenzyme Q10 (CoQ10)—a completely independent antioxidant system that operates in parallel to GPX4. This discovery fundamentally changed our understanding of ferroptosis defense: cells don’t rely on a single guardian but maintain multiple, redundant protective systems.

The Discovery Story

The FSP1-CoQ10 axis was discovered simultaneously by three independent research teams in 2019:

Eikan Mishima and Takaaki Akaike in Japan were studying why certain cells resisted GPX4 inhibition. They identified a previously uncharacterized protein (initially called AIFM2) that, when overexpressed, protected cells from ferroptosis even without functional GPX4. They renamed it FSP1—Ferroptosis Suppressor Protein 1.

Kivanç Birsoy and Stuart Schreiber‘s groups at MIT and Harvard used genetic screens to find genes that, when deleted, sensitized cells to ferroptosis. They found that removing FSP1 made cells more vulnerable, while adding extra FSP1 provided protection.

Jen-Tsan Chi‘s group at Duke University independently identified the same protein through similar approaches, confirming its role as a powerful ferroptosis suppressor.

Critically, all three groups discovered that FSP1 works by reducing coenzyme Q10 (CoQ10), creating a lipophilic antioxidant that prevents lipid peroxidation through a mechanism completely different from GPX4.

What is FSP1?

FSP1 is an oxidoreductase enzyme—it transfers electrons from one molecule to another. Specifically, FSP1 uses NAD(P)H (a cellular reducing agent) to reduce coenzyme Q10 (ubiquinone) to its antioxidant form, ubiquinol.

The Chemical Reaction:
Ubiquinone (oxidized CoQ10) + NAD(P)H → Ubiquinol (reduced CoQ10) + NAD(P)+

Why This Matters:
Ubiquinol is a powerful lipophilic (fat-soluble) antioxidant that can directly trap lipid radicals in cell membranes, preventing the chain reaction of lipid peroxidation that drives ferroptosis. By continuously regenerating ubiquinol, FSP1 maintains a protective antioxidant shield.

What is Coenzyme Q10?

Coenzyme Q10 (CoQ10), also called ubiquinone, is a small lipid-soluble molecule found throughout the body. Most people know CoQ10 as a dietary supplement or as a component of the mitochondrial electron transport chain where it helps generate cellular energy (ATP).

Structure and Properties:

• CoQ10 has a quinone head group (which can be reduced to a hydroquinone)
• A long hydrophobic tail (10 isoprenoid units—hence “Q10”) that anchors it in membranes
• Exists in oxidized form (ubiquinone) or reduced form (ubiquinol)

Where It’s Found:

• Cell membranes (plasma membrane, ER, mitochondrial membranes)
• Particularly abundant in mitochondria
• Present in lipoproteins circulating in blood

CoQ10 can be synthesized by cells or obtained from the diet. The body’s ability to make CoQ10 decreases with age, which is why CoQ10 supplements are popular.

How the FSP1-CoQ10 Axis Prevents Ferroptosis

The FSP1-CoQ10 system protects against ferroptosis through a elegantly simple mechanism:

Step 1: FSP1 Localization
FSP1 localizes to the plasma membrane and possibly other cellular membranes. It attaches to membranes through a lipid modification (myristoylation) at its N-terminus, positioning it exactly where lipid peroxidation occurs.

Step 2: CoQ10 Reduction
FSP1 uses electrons from NAD(P)H to reduce ubiquinone (oxidized CoQ10) to ubiquinol (reduced CoQ10). This happens continuously, maintaining a pool of reduced, antioxidant-active CoQ10.

Step 3: Radical Trapping
Ubiquinol acts as a radical-trapping antioxidant (RTA). When lipid peroxidation begins—iron catalyzes the formation of lipid radicals—ubiquinol donates a hydrogen atom to these radicals, neutralizing them before they can propagate a chain reaction.

The Chain Reaction Prevention:

• Lipid peroxidation is a chain reaction: one lipid radical can create many more
• Ubiquinol breaks this chain by reducing lipid radicals back to stable lipids
• By stopping the propagation, ubiquinol prevents the accumulation of toxic lipid peroxides

Step 4: FSP1 Regeneration
When ubiquinol donates its hydrogen atom, it becomes oxidized back to ubiquinone. FSP1 immediately reduces it again, creating a continuous cycle of antioxidant protection.

FSP1-CoQ10 vs. GPX4-GSH: Two Parallel Systems

The FSP1-CoQ10 axis and the GPX4-glutathione system both prevent ferroptosis but work through fundamentally different mechanisms:

Different Chemistry:

• GPX4: Enzymatically reduces lipid hydroperoxides that have already formed (fixes the damage)
• FSP1-CoQ10: Traps lipid radicals before they form hydroperoxides (prevents the damage)

Different Locations:

• GPX4: Works throughout the cell, including the cytoplasm and membranes
• FSP1: Primarily membrane-associated, working right where lipid peroxidation happens

Different Cofactors:

• GPX4: Requires glutathione, which requires cysteine, which requires system xc⁻
• FSP1-CoQ10: Requires NAD(P)H and CoQ10, independent of cysteine/glutathione

Different Vulnerabilities:

• GPX4 system: Disabled by erastin (blocks cysteine import), RSL3 (directly inhibits GPX4), glutathione depletion
• FSP1 system: Disabled by iFSP1 (FSP1 inhibitor), CoQ10 biosynthesis inhibitors, NAD(P)H depletion

Redundancy is Protection:
The existence of two independent systems means cells have backup protection. To fully sensitize a cell to ferroptosis, you often need to disable both systems. This redundancy explains why:

• Some cells survive GPX4 inhibition (they rely on FSP1-CoQ10)
• Some cells survive FSP1 inhibition (they rely on GPX4)
• Combining GPX4 and FSP1 inhibition is particularly lethal

FSP1 Localization and Myristoylation

FSP1’s protective function depends critically on its location:

Myristoylation:
FSP1 undergoes N-terminal myristoylation—the attachment of a 14-carbon fatty acid (myristate) to its first glycine residue. This lipid modification acts like an anchor, tethering FSP1 to cell membranes.

Why Location Matters:
Lipid peroxidation happens in membranes. By localizing FSP1 to membranes, the cell ensures that CoQ10 reduction happens exactly where the resulting ubiquinol is needed. Without myristoylation, FSP1 remains in the cytoplasm and provides minimal protection.

Plasma Membrane Focus:
FSP1 is particularly enriched at the plasma membrane (the cell’s outer boundary), though it may also localize to other membranes. This positioning protects the critical barrier between the cell and its environment.

FSP1 in Different Cell Types and Cancers

FSP1 expression varies dramatically across cell types, creating patterns of ferroptosis resistance:

High FSP1 Expression:

• Certain cancer cell lines (ovarian cancer, lymphoma, some breast cancers)
• Adipocytes (fat cells)
• Some immune cell populations

These cells can resist ferroptosis even when GPX4 is inhibited, making them harder to kill with ferroptosis-inducing therapies that only target GPX4.

Low FSP1 Expression:

• Many epithelial cells
• Certain neurons
• Various cancer types

These cells depend heavily on GPX4 for ferroptosis protection and are highly vulnerable when GPX4 is inhibited.

Cancer Resistance:
Some tumors acquire resistance to ferroptosis-inducing drugs by upregulating FSP1. This represents an important resistance mechanism that could limit the effectiveness of GPX4-targeting cancer therapies. Conversely, tumors with naturally low FSP1 may be excellent candidates for such treatments.

Therapeutic Implications

The discovery of the FSP1-CoQ10 axis has major implications for medicine:

Cancer Treatment:

FSP1 as a Resistance Mechanism:

• Tumors may evade GPX4-targeting drugs by increasing FSP1 expression
• Testing for FSP1 levels could predict treatment response
• Dual targeting (GPX4 + FSP1) may be necessary for some cancers

FSP1 Inhibitors:
Researchers have developed FSP1 inhibitors like iFSP1 that can block this pathway. Combining FSP1 inhibitors with GPX4 inhibitors creates a “double blockade” that eliminates redundancy and powerfully induces ferroptosis.

Neuroprotection:

Enhancing FSP1 Activity:
In neurodegenerative diseases where ferroptosis harms neurons, boosting FSP1-CoQ10 activity could provide protection:

• Supplementing with CoQ10 (already widely available)
• Increasing FSP1 expression genetically or pharmacologically
• Ensuring adequate NAD(P)H availability

Clinical Promise:
CoQ10 supplementation is safe and already used for various conditions. If FSP1-CoQ10 protection proves important in neurodegeneration, this represents a readily translatable therapeutic approach.

Cardiovascular Protection:

Similar to neurons, heart cells may benefit from FSP1-CoQ10 enhancement during:

• Heart attack (ischemia-reperfusion injury)
• Heart failure
• Cardiotoxic drug exposure

CoQ10 Supplementation: Does It Help?

Given FSP1’s dependence on CoQ10, a natural question arises: can taking CoQ10 supplements protect against ferroptosis?

Theoretical Potential:

• Supplementation increases cellular CoQ10 levels
• More substrate for FSP1 could enhance antioxidant capacity
• CoQ10 is safe and well-tolerated

Practical Considerations:

• CoQ10 bioavailability varies (ubiquinol form may be better absorbed)
• Whether dietary CoQ10 reaches the right cellular locations is unclear
• Effects likely depend on baseline FSP1 expression
• No direct clinical evidence yet for ferroptosis-related diseases

Current Status:
While promising, the ferroptosis-protective effects of CoQ10 supplementation in humans remain unproven. Research is ongoing to determine if and when such supplementation might be beneficial.

The Broader Picture: Multiple Defense Layers

The FSP1-CoQ10 axis is part of an increasingly complex picture of ferroptosis defense:

Three Major Systems Identified:

1. GPX4-Glutathione: Repairs lipid peroxide damage
2. FSP1-CoQ10: Prevents lipid peroxidation propagation
3. GCH1-BH4: Provides alternative antioxidant protection

Why Multiple Systems?

• Redundancy ensures cells aren’t vulnerable to single-point failures
• Different systems use different metabolic resources (diversification)
• Systems may predominate in different cell types or conditions
• Evolutionary selection favored multiple protective mechanisms

Clinical Significance:
For ferroptosis-based therapies to work, we may need to target multiple systems simultaneously. Understanding which systems a particular cell or tumor relies on most heavily will guide precision medicine approaches.

FSP1 Regulation

How cells control FSP1 expression and activity is an active research area:

Transcriptional Control:
Various signaling pathways and transcription factors influence FSP1 gene expression, though the full regulatory network remains to be elucidated.

Metabolic Regulation:
NAD(P)H availability links FSP1 activity to cellular metabolism:

• Glucose metabolism (via pentose phosphate pathway) generates NADPH
• Mitochondrial function affects NAD(P)H pools
• Metabolic stress may influence FSP1’s protective capacity

Post-Translational Modifications:
Phosphorylation, ubiquitination, and other modifications may regulate FSP1 stability, localization, or activity.

Current Research Questions

Many aspects of the FSP1-CoQ10 axis remain under investigation:

• How do cells regulate FSP1 vs. GPX4 expression in different contexts?
• Can we predict which system a given cell relies on most?
• What determines whether FSP1 or GPX4 is the dominant protector?
• How do these systems communicate or coordinate?
• Are there additional undiscovered ferroptosis defense systems?
• Can we safely manipulate the FSP1-CoQ10 axis therapeutically?

Key Takeaways

The FSP1-CoQ10 axis revolutionized our understanding of ferroptosis:

• Cells have multiple, independent ferroptosis defense systems
• FSP1 works by regenerating the antioxidant form of CoQ10
• This system operates completely independently of GPX4
• FSP1 expression varies widely, creating different vulnerabilities
• Therapeutic targeting requires considering multiple defense pathways
• The discovery opened new possibilities for both inducing and preventing ferroptosis

Understanding the FSP1-CoQ10 axis reveals the sophisticated, multi-layered defenses cells employ against ferroptosis. Rather than a single guardian, cells maintain a network of protective systems—a finding that has profound implications for both basic biology and medicine.